Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02618343 · ClinicalTrials.gov registry record · NA

EMS Use of Isopropyl Alcohol Aromatherapy Versus Ondansetron

A NA study, sponsored by The University of Texas Health Science Center at San Antonio.

Completed
Registry status
NA
Development phase
51
Enrollment target

NCT02618343 is a NA study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 51 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02618343, a NA study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.

COMPLETED
Registry status
NA
Development phase
51 participants
Enrollment target

Study Summary

Nausea is a common symptom encountered in the Emergency Medical Services (EMS) environment that is often treated with oral or intravenous anti-emetic medications. Research Design/Plan: This will be a randomized equivalence study comparing the reduction in a patient's reported level of nausea after treatment with either Ondansetron or IPA Methods: Patients who report nausea and/or vomiting in the normal evaluation and care of after calling 911 for Emergency Medical Care will be offered enrollment in the study. A short script will be attached to the outside of each study packet providing information about the study and its risks and benefits. Verbal or written (waiver of informed consent will be requested) permission will be obtained to start randomization. If the patient agrees to enroll then the study packet will be opened and utilized. All Advanced Life Support Ambulances in the San Antonio Fire Department will have sealed numbered opaque boxes or envelopes with either: 70% Isopropyl Alcohol swabs or ondansetron. Six Visual Nausea Severity Scoring cards will be provided with a marking pen to record timed nausea levels before and upon arrival to the Emergency Department and 15 minutes after treatment whichever comes first. Clinical Relevance: This treatment has not been studied in the unique environment encountered by Paramedics in the Pre-Hospital setting. If this treatment is found to be effective, it many offer a very simple, extremely inexpensive and non-invasive (basic life support) approach for the treatment of nausea.

Interventions

  • DRUG Ondansetron
  • DRUG IPA

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2016-10-04
Est. Completion 2019-03-01
Phase NA

What the Registry Record Tells You About NCT02618343

The ClinicalTrials.gov registry entry for NCT02618343 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Ondansetron is the first listed.

NCT02618343 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02618343 about?

NCT02618343 is a clinical study titled "EMS Use of Isopropyl Alcohol Aromatherapy Versus Ondansetron". Nausea is a common symptom encountered in the Emergency Medical Services (EMS) environment that is often treated with oral or intravenous anti-emetic medications. Research Design/Plan: This will be a randomized equivalence study comparing the reduction in a patient's reported level of nausea after t...

What is the current status of trial NCT02618343?

This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2016-10-04. Estimated completion is 2019-03-01.

What interventions are being tested in trial NCT02618343?

The interventions under investigation include: Ondansetron (DRUG), IPA (DRUG).

Who is sponsoring clinical trial NCT02618343?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.